BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $254 | +11.9% | 5,581 | -0.2% | 0.01% | 0.0% |
| Q1 2023 | $227 | -23.8% | 5,594 | -4.3% | 0.01% | -22.2% |
| Q4 2022 | $298 | -99.9% | 5,844 | -0.6% | 0.01% | -18.2% |
| Q3 2022 | $317,000 | -16.8% | 5,877 | -0.8% | 0.01% | -8.3% |
| Q2 2022 | $381,000 | -18.1% | 5,927 | -1.1% | 0.01% | -14.3% |
| Q1 2022 | $465,000 | -21.6% | 5,994 | -13.2% | 0.01% | -17.6% |
| Q4 2021 | $593,000 | +5.0% | 6,904 | -1.8% | 0.02% | -5.6% |
| Q3 2021 | $565,000 | -0.2% | 7,029 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $566,000 | -4.6% | 7,029 | 0.0% | 0.02% | -5.3% |
| Q1 2021 | $593,000 | +5.1% | 7,029 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $564,000 | -10.5% | 7,029 | -10.2% | 0.02% | -20.8% |
| Q3 2020 | $630,000 | -6.5% | 7,829 | 0.0% | 0.02% | -14.3% |
| Q2 2020 | $674,000 | +6.0% | 7,829 | 0.0% | 0.03% | -6.7% |
| Q1 2020 | $636,000 | -6.3% | 7,829 | -3.5% | 0.03% | +20.0% |
| Q4 2019 | $679,000 | -23.8% | 8,116 | -20.4% | 0.02% | -26.5% |
| Q3 2019 | $891,000 | +6.7% | 10,191 | 0.0% | 0.03% | +3.0% |
| Q2 2019 | $835,000 | -7.1% | 10,191 | -7.9% | 0.03% | -13.2% |
| Q1 2019 | $899,000 | +23.5% | 11,061 | 0.0% | 0.04% | +11.8% |
| Q4 2018 | $728,000 | -16.0% | 11,061 | -1.6% | 0.03% | -8.1% |
| Q3 2018 | $867,000 | +13.0% | 11,241 | +8.2% | 0.04% | +2.8% |
| Q2 2018 | $767,000 | +4.5% | 10,391 | -8.0% | 0.04% | +2.9% |
| Q1 2018 | $734,000 | 0.0% | 11,291 | -0.5% | 0.04% | +2.9% |
| Q4 2017 | $734,000 | -7.6% | 11,351 | -10.3% | 0.03% | -12.8% |
| Q3 2017 | $794,000 | -1.6% | 12,651 | -5.1% | 0.04% | -4.9% |
| Q2 2017 | $807,000 | +0.5% | 13,326 | -13.9% | 0.04% | -2.4% |
| Q1 2017 | $803,000 | +8.4% | 15,476 | -7.3% | 0.04% | +5.0% |
| Q4 2016 | $741,000 | -14.4% | 16,701 | -8.2% | 0.04% | -14.9% |
| Q3 2016 | $866,000 | -83.8% | 18,201 | -84.6% | 0.05% | -84.1% |
| Q2 2016 | $5,354,000 | -62.6% | 118,404 | -66.0% | 0.30% | -63.8% |
| Q1 2016 | $14,302,000 | +8.8% | 348,162 | +1.1% | 0.82% | +3.2% |
| Q4 2015 | $13,141,000 | +24.5% | 344,460 | +7.2% | 0.79% | +18.3% |
| Q3 2015 | $10,556,000 | -51.4% | 321,343 | +3.5% | 0.67% | -48.0% |
| Q2 2015 | $21,705,000 | +2.9% | 310,377 | +0.8% | 1.28% | +2.6% |
| Q1 2015 | $21,100,000 | -5.3% | 308,035 | +1.3% | 1.25% | -2.6% |
| Q4 2014 | $22,277,000 | -1.8% | 303,955 | -3.8% | 1.28% | -7.1% |
| Q3 2014 | $22,679,000 | -0.2% | 316,001 | +0.6% | 1.38% | +1.7% |
| Q2 2014 | $22,715,000 | -1.0% | 314,176 | +0.8% | 1.36% | -5.2% |
| Q1 2014 | $22,937,000 | +6.6% | 311,726 | +0.7% | 1.43% | +3.5% |
| Q4 2013 | $21,523,000 | +11.2% | 309,460 | +5.0% | 1.39% | +3.0% |
| Q3 2013 | $19,362,000 | -5.2% | 294,750 | -0.0% | 1.35% | -6.8% |
| Q2 2013 | $20,423,000 | -2.8% | 294,831 | +1.9% | 1.44% | -6.5% |
| Q1 2013 | $21,015,000 | – | 289,297 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |